January 2017 Health Product InfoWatch

The goal of the Health Product InfoWatch is to raise awareness and to provide clinically relevant information to healthcare professionals concerning marketed health products and their safety. In some cases, information is intended to stimulate reporting of similar adverse reactions. Each publication includes a monthly recap of health product advisories and summary safety reviews, as well as a growing selection of new health product safety information.
 

In this issue: 

• Monthly recap
• New information: 
  • Medication error alert: Eligard (leuprolide acetate): Reconstitution and administration errors and risk of lack of efficacy
  • Medication error alert: Methotrexate: Serious dosing errors
  • Product monograph update: Mekinist (trametinib)
  • Product monograph update: Neurontin (gabapentin)